{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T13:29:46Z","timestamp":1791120586828,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2006,5,19]],"date-time":"2006-05-19T00:00:00Z","timestamp":1147996800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.1007\/s00213-006-0413-4","type":"journal-article","created":{"date-parts":[[2006,5,18]],"date-time":"2006-05-18T13:25:52Z","timestamp":1147958752000},"page":"229-236","source":"Crossref","is-referenced-by-count":60,"title":["Evaluation of factors influencing medication compliance in inpatient treatment of psychotic disorders"],"prefix":"10.1007","volume":"187","author":[{"given":"Birgit","family":"Janssen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Gaebel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Haerter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Komaharadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit","family":"Lindel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Weinmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,5,19]]},"reference":[{"key":"413_CR1","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1176\/ajp.150.6.873","volume":"150","author":"XF Amador","year":"1993","unstructured":"Amador XF, Strauss DH, Yale SA (1993) Assessment of insight in psychosis. Am J Psychiatry 150:873\u2013879","journal-title":"Am J Psychiatry"},{"key":"413_CR2","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/0006-3223(92)90143-N","volume":"32","author":"RW Buchanan","year":"1992","unstructured":"Buchanan RW, Kirkpatrick B, Summerfelt A, Hanlon TE, Levine J, Carpenter WT (1992) Clinical predictors of relapse following neuroleptic withdrawal. Biol Psychiatry 32:72\u201378","journal-title":"Biol Psychiatry"},{"issue":"Pt 1","key":"413_CR3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1348\/147608304322874236","volume":"77","author":"R Carrick","year":"2004","unstructured":"Carrick R, Mitchell A, Powell RA, Lloyd KR (2004) The quest for well-being: a qualitative study of the experience of taking antipsychotic medication. Psychol Psychother 77(Pt 1):19\u201333","journal-title":"Psychol Psychother"},{"issue":"7","key":"413_CR4","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1001\/archpsyc.62.7.717","volume":"62","author":"JC Day","year":"2005","unstructured":"Day JC, Bentall RP, Roberts C, Randall F, Rogers A, Cattell D, Healy D, Rae P, Power C (2005) Attitudes toward antipsychotic medication: the impact of clinical variables and relationships with health professionals. Arch Gen Psychiatry 62(7):717-724","journal-title":"Arch Gen Psychiatry"},{"issue":"Suppl 16","key":"413_CR5","first-page":"24","volume":"64","author":"JM Davis","year":"2003","unstructured":"Davis JM, Chen N (2003) Choice of maintenance medication for schizophrenia. J Clin Psychiatry 64(Suppl 16):24\u201333","journal-title":"J Clin Psychiatry"},{"key":"413_CR6","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1176\/appi.ajp.159.1.103","volume":"159","author":"CR Dolder","year":"2002","unstructured":"Dolder CR, Lacro JP, Dunn LB, Jeste DV (2002) Antipsychotic medication adherence: is there a difference between typical and atypical agents? Am J Psychiatry 159:103\u2013108","journal-title":"Am J Psychiatry"},{"key":"413_CR7","first-page":"1041","volume":"40","author":"RE Drake","year":"1989","unstructured":"Drake RE, Wallach MA (1989) Substance abuse among the chronic mentally ill. Hosp Community Psychiatry 40:1041\u20131046","journal-title":"Hosp Community Psychiatry"},{"issue":"Suppl 16","key":"413_CR8","first-page":"10","volume":"64","author":"WW Fleischhacker","year":"2002","unstructured":"Fleischhacker WW, Oehl MA, Hummer M (2002) Factors influencing compliance in schizophrenia patients. J Clin Psych 64(Suppl 16):10\u201313","journal-title":"J Clin Psych"},{"issue":"6","key":"413_CR9","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1055\/s-2007-1017019","volume":"21","author":"W Gaebel","year":"1988","unstructured":"Gaebel W, Pietzcker A, Ulrich G, Schley J, Muller-Oerlinghausen B (1988) Predictors of neuroleptic treatment response in acute schizophrenia: results of a treatment study with perazine. Pharmacopsychiatry 21(6):384\u2013386","journal-title":"Pharmacopsychiatry"},{"key":"413_CR10","doi-asserted-by":"crossref","first-page":"394","DOI":"10.4088\/JCP.v62n0515","volume":"62","author":"MF Grunebaum","year":"2001","unstructured":"Grunebaum MF, Weiden PJ, Olfson M (2001) Medication supervision and adherence of persons with psychotic disorders in residential treatment settings: a pilot study. J Clin Psychiatry 62:394\u2013399","journal-title":"J Clin Psychiatry"},{"key":"413_CR11","unstructured":"Guy W (1976) ECDEU assessment manual for psychopharmacology. US Department of Health, Education, and Welfare Publication, Rockville, MD, National Institute of Mental Health, pp 76\u2013338"},{"key":"413_CR12","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1017\/S0033291700030282","volume":"22","author":"TP Hogan","year":"1992","unstructured":"Hogan TP, Awad AG (1992) Subjective response to neuroleptics and outcome in schizophrenia: a re-examination comparing two measures. Psychol Med 22:347\u2013352","journal-title":"Psychol Med"},{"key":"413_CR13","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1600-0447.1999.tb10842.x","volume":"100","author":"O Kampman","year":"1999","unstructured":"Kampman O, Lehtinen K (1999) Compliance in psychoses. Acta Psychiatr Scand 100:167\u2013175","journal-title":"Acta Psychiatr Scand"},{"key":"413_CR14","volume-title":"Positive and negative syndromes in schizophrenia","author":"SR Kay","year":"1991","unstructured":"Kay SR (1991) Positive and negative syndromes in schizophrenia. Brunner and Mazel, New York"},{"key":"413_CR15","doi-asserted-by":"crossref","first-page":"892","DOI":"10.4088\/JCP.v63n1007","volume":"63","author":"JP Lacro","year":"2002","unstructured":"Lacro JP, Dunn LB, Dolder CR, Leckband SG, Jeste DV (2002) Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. J Clin Psychiatry 63:892\u2013909","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"413_CR16","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1600-0447.2005.00554.x","volume":"112","author":"M Lambert","year":"2005","unstructured":"Lambert M, Conus P, Lubman DI, Wade D, Yuen H, Moritz S, Naber D, McGorry PD, Schimmelmann BG (2005). The impact of substance use disorders on clinical outcome in 643 patients with first-episode psychosis. Acta Psychiatr Scand 112(2):141-148","journal-title":"Acta Psychiatr Scand"},{"issue":"2 Suppl","key":"413_CR17","first-page":"1","volume":"161","author":"AF Lehman","year":"2004","unstructured":"Lehman AF, Lieberman JA, Dixon LB, McGlashan TH, Miller AL, Perkins DO, Kreyenbuhl J (2004) Practice guideline for the treatment of patients with schizophrenia, 2nd edition. Am J Psychiatry 161(2 Suppl):1\u201356","journal-title":"Am J Psychiatry"},{"key":"413_CR18","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1192\/bjp.168.6.718","volume":"168","author":"R Macpherson","year":"1996","unstructured":"Macpherson R, Jerrom B, Hughes A (1996) Relationship between insight, educational background and cognition in schizophrenia. Br J Psychiatry 168:718\u2013722","journal-title":"Br J Psychiatry"},{"issue":"Suppl 16","key":"413_CR19","first-page":"3","volume":"64","author":"SR Marder","year":"2003","unstructured":"Marder SR (2003) Overview of partial compliance. J Clin Psychiatry 64(Suppl 16):3\u20139","journal-title":"J Clin Psychiatry"},{"key":"413_CR20","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/00005053-198901000-00007","volume":"177","author":"JP McEvoy","year":"1989","unstructured":"McEvoy JP, Apperson LJ, Appelbaum PS, Ortlip P, Brecosky J, Hammill K, Geller JL, Roth LH (1989) Insight in schizophrenia. Its relationship to acute psychopathology. J Nerv Ment Dis 177:43\u201347","journal-title":"J Nerv Ment Dis"},{"issue":"8","key":"413_CR21","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1001\/archpsyc.1997.01830200030005","volume":"45","author":"CR Miner","year":"1997","unstructured":"Miner CR, Rosenthal RN, Hellerstein DJ, Muenz LR (1997) Prediction of compliance with outpatient referral in patients with schizophrenia and psychoactive substance use disorders. Arch Gen Psychiatry 45(8):706\u2013712","journal-title":"Arch Gen Psychiatry"},{"key":"413_CR22","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/BF00788920","volume":"32","author":"C Nageotte","year":"1997","unstructured":"Nageotte C, Sullivan G, Duan N, Camp PL (1997) Medication compliance among the seriously mentally ill in a public mental health system. Soc Psychiatry Psychiatr Epidemiol 32:49\u201356","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"413_CR23","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1176\/appi.ps.51.2.216","volume":"51","author":"M Olfson","year":"2000","unstructured":"Olfson M, Mechanic D, Hansell S, Boyer CA, Walkup J, Weiden PJ (2000) Predicting medication noncompliance after hospital discharge among patients with schizophrenia. Psychiatr Serv 51:216\u2013222","journal-title":"Psychiatr Serv"},{"key":"413_CR24","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1176\/ps.47.8.853","volume":"47","author":"RR Owen","year":"1996","unstructured":"Owen RR, Fischer EP, Booth BM, Cuffel BJ (1996) Medication noncompliance and substance abuse among patients with schizophrenia. Psychiatr Serv 47:853\u2013858","journal-title":"Psychiatr Serv"},{"key":"413_CR25","doi-asserted-by":"crossref","first-page":"382","DOI":"10.4088\/JCP.v61n0511","volume":"61","author":"R Rosenheck","year":"2000","unstructured":"Rosenheck R, Chang S, Choe Y, Cramer J, Xu W, Thomas J, Henderson W, Charney D (2000) Medication continuation and compliance: a comparison of patients treated with clozapine and haloperidol. J Clin Psychiatry 61:382\u2013386","journal-title":"J Clin Psychiatry"},{"key":"413_CR26","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/00005053-199902000-00006","volume":"187","author":"TE Smith","year":"1999","unstructured":"Smith TE, Hull JW, Goodman M, Hedayat-Harris A, Willson DF, Israel LM, Munich RL (1999) The relative influences of symptoms, insight, and neurocognition on social adjustment in schizophrenia and schizoaffective disorder. J Nerv Ment Dis 187:102\u2013108","journal-title":"J Nerv Ment Dis"},{"key":"413_CR27","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1348\/014466502760387533","volume":"41","author":"M Startup","year":"2002","unstructured":"Startup M, Jackson MC, Bendix S (2002) The concurrent validity of the global assessment of functioning (GAF). Br J Clin Psychol 41:417\u2013422","journal-title":"Br J Clin Psychol"},{"issue":"1","key":"413_CR28","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/oxfordjournals.schbul.a006853","volume":"27","author":"TM Tattan","year":"2001","unstructured":"Tattan TM, Creed FH (2001) Negative symptoms of schizophrenia and compliance with medication. Schizophr Bull 27(1):149\u2013155","journal-title":"Schizophr Bull"},{"key":"413_CR29","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0920-9964(01)00309-7","volume":"57","author":"L Voruganti","year":"2002","unstructured":"Voruganti L, Cortese L, Owyeumi L, Kotteda V, Cernovsky Z, Zirul S, Awad A (2002) Switching from conventional to novel antipsychotic drugs: results of a prospective naturalistic study. Schizophr Res 57:201\u2013208","journal-title":"Schizophr Res"},{"issue":"8","key":"413_CR30","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.4088\/JCP.v65n0812","volume":"65","author":"S Weinmann","year":"2004","unstructured":"Weinmann S, Janssen B, Gaebel W (2004) Switching antipsychotics in inpatient schizophrenia care\u2014predictors and outcome. J Clin Psychiatry 65(8):1099\u20131105","journal-title":"J Clin Psychiatry"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-006-0413-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-006-0413-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-006-0413-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T16:31:24Z","timestamp":1558629084000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-006-0413-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5,19]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["413"],"URL":"https:\/\/doi.org\/10.1007\/s00213-006-0413-4","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,5,19]]}}}